Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: A French multicentre study

Author:

Ha Van Georges1ORCID,Schuldiner Sophie2,Sultan Ariane34,Bouillet Benjamin567,Martini Jacques8,Vouillarmet Julien9,Menai Medhi10,Foucher Aurélie10,Bourron Olivier11,Hartemann Agnes11,Perrier Antoine1

Affiliation:

1. Diabetes Department APHP, Hospital Pitie Salpetriere Paris France

2. Endocrinology Department University Hospital Center Nimes France

3. Nutrition‐Diabetes Department University Hospital of Montpellier Montpellier France

4. PhyMedExp, INSERM U1046, CNRS UMR 9214 University of Montpellier Montpellier France

5. Endocrinology and Diabetology Department University Hospital Center Dijon France

6. INSERM Dijon France

7. University of Bourgogne Franche‐Comté LNC UMR1231 Dijon France

8. Endocrinology Department University Hospital Center Toulouse France

9. Endocrinology Department University Hospital Center Lyon France

10. IHU ICAN Foundation for Innovation in Cardio Metabolism and Nutrition Paris France

11. Diabetes Department Sorbonne University AP‐HP, Hôpital Pitié‐Salpêtrière Paris France

Abstract

AbstractObjectiveTo assess the relationship between the site, ischaemia, neuropathy, bacterial infection, area, depth (SINBAD) score and major adverse foot events in patients with diabetes and foot ulcers.MethodsFor this retrospective ancillary study, patients (n = 537) followed for a diabetic foot ulcer (DFU) in six French hospitals were included between 1 February 2019 and 17 March 2019, and between 1 February 2020 and 17 March 2020. The SINBAD score was assessed at inclusion. The frequency of a composite outcome consisting of eight major adverse foot events (MAFE) was assessed after 5–6 months of follow‐up: hospitalisation for DFU, septic surgery, revascularisation, minor amputation, major amputation, death, secondary infection and ulcer recurrence. A logistical regression explored the link between the SINBAD score and MAFE and each of its component.ResultsA low SINBAD score (from 0 to 3) was observed in 61% of patients and a high (from 4 to 6) in 39%. MAFE occurred in, respectively, 24% and 28% of these patients. Multivariate analyses showed a significant relationship between the SINBAD score and MAFE, with the continuous SINBAD score: odds ratio (OR) 1.72 [95% CI (1.51–1.97)] or dichotomic SINBAD score (values: 0–3 and 4–6): OR 3.71 [95% CI (2.54–5.42)]. The SINBAD score (continuous or dichotomic) at inclusion was also significantly associated with six out of the eight components of the MAFE.ConclusionsThe SINBAD score is a useful tool for predicting major adverse foot events.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Improved survival of the diabetic foot: the role of the specialized foot clinic;Edmonds ME;Q J Med,1986

2. Improvement of diabetic foot care after the implementation of the International Consensus on the Diabetic Foot (ICDF): result of 5‐year prospective study;Fusilli D;Diabetes Res Clin Pract,2005

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3